Daniel E. Ryweck's most recent trade in SILO Pharma Inc was a trade of 50,000 Options (right to buy) done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SILO Pharma Inc | Daniel E. Ryweck | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 50,000 | 55,000 | - | - | Options (right to buy) | |
| SILO Pharma Inc | Daniel E. Ryweck | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.13 per share. | 26 May 2023 | 1,000 | 5,000 | - | 2.1 | 2,126 | Common Stock |